ANI Pharmaceuticals | ANIP - Caixa e Equivalentes





Caixa e Equivalentes Alterar Data
AbbVie USD 5.23B 400M 2025-12
ANI Pharmaceuticals USD 285.58M 22.98M 2025-12
Assertio Holdings USD 38.5M 8.59M 2025-09
Aurora Cannabis CAD 56.36M 39.33M 2025-12
Canopy Growth CAD 371.32M 73.26M 2025-12
Eli Lilly USD 7.27B 2.52B 2025-12
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Hikma Pharmaceutical USD 236M 48M 2025-06
Knight Therapeutics CAD 76.45M 5.43M 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Novartis USD 9.56B 2.9B 2025-09
Omeros USD 1.9M 2.36M 2025-06
Perrigo USD 432.1M 22.1M 2025-09
Sun Pharmaceuticals INR 113.32B 33.19B 2025-03
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12